Global Near_Patient Molecular Solutions Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Near-Patient Molecular Solutions Global Market Report 2025

Name: Near-Patient Molecular Solutions Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types), By Technology (Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based), By End-User (Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Near-Patient Molecular Solutions Market Overview

• Near-Patient Molecular Solutions market size has reached to $4.13 billion in 2024

• Expected to grow to $6.656 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%

• Growth Driver: Surge In Demand For Home-based Point-Of-Care Devices Fueling The Growth Of The Market Due To Increasing Consumer Autonomy And Convenience

• Market Trend: Integration Of Advanced Molecular Amplification Technologies To Enhance Near-Patient Diagnostic Performance

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Near-Patient Molecular Solutions Market?

Near-patient molecular solutions are diagnostic tests that use molecular biology techniques, such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) detection, and are performed at or very close to where the patient receives care. These tests analyze small biological samples on-site instead of sending them to a central laboratory, allowing rapid and accurate detection of pathogens or biomarkers using portable or simplified instruments. By delivering quick and reliable results in outpatient, emergency, or remote settings, they support timely treatment decisions and better health outcomes.

The main product types of near-patient molecular solutions include infectious disease testing kits, Urinalysis Testing Kits, tumor or cancer markers, pregnancy and fertility, hematology testing kits, glucose monitoring kits, drugs-of-abuse testing kits, coagulation monitoring kits, cardiometabolic monitoring kits, and others. Infectious disease testing kits are diagnostic tools designed to rapidly detect and identify pathogens such as bacteria, viruses, or parasites in patient samples to aid in timely disease diagnosis and treatment. The different technologies involved are polymerase chain reaction (PCR)-based, genetic sequencing-based, hybridization-based, and are used for several end-users, including hospitals and clinics, ambulatory care centers, research laboratories, home care settings, and others.

Near_Patient Molecular Solutions Market Size and growth rate 2025 to 2029: Graph

What Is The Near-Patient Molecular Solutions Market Size 2025 And Growth Rate?

What Is The Near-Patient Molecular Solutions Market Growth Forecast?

The near-patient molecular solutions market size is expected to see strong growth in the next few years. It will grow to $6.656 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing burden of chronic and emerging infectious diseases, rising adoption of precision and personalized medicine approaches, growing integration of near-patient testing in primary care networks, surge in government initiatives to strengthen diagnostic infrastructure, expansion of community and home-based testing models, and rising healthcare expenditure supporting diagnostic accessibility. Major trends in the forecast period include technological advancements in microfluidic cartridge design, advancements in multiplex molecular assay platforms, innovations in sample-to-answer portable analyzers, developments in connectivity-enabled data reporting systems, research and development in reagent miniaturization for field applications, and innovations in fully automated near-patient molecular workflows.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Near-Patient Molecular Solutions Market Segmented?

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: ovulation testing kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

What Is Driving The Near-Patient Molecular Solutions Market? Surge In Demand For Home-based Point-Of-Care Devices Fueling The Growth Of The Market Due To Increasing Consumer Autonomy And Convenience

Growing demand for home-based point-of-care devices is expected to propel the growth of the near patient molecular solutions market going forward. Home-based point-of-care devices are diagnostic testing systems that patients or non-laboratory users operate at or near their home, enabling sample collection, analysis, or result reading outside a conventional central laboratory setting and in or close to the place of care. The growing demand for home-based point-of-care devices is increasing due to the rising consumer preference for convenient, rapid, and accessible health monitoring outside traditional healthcare settings. Near-patient molecular solutions support the home-based point-of-care devices by providing accurate, rapid, and portable molecular diagnostics that can be reliably used outside traditional laboratory settings. For instance, in February 2023, the US Food & Drug Administration (FDA), a US-based government agency, reported in its 2023 COVID-19 testing update that there was one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Therefore, growing demand for home-based point-of-care devices is driving the growth of the near-patient molecular solutions industry.

Who Are The Major Players In The Global Near-Patient Molecular Solutions Market?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

What Are The Key Trends Of The Global Near-Patient Molecular Solutions Market? Integration Of Advanced Molecular Amplification Technologies To Enhance Near-Patient Diagnostic Performance

Major companies operating in the near-patient molecular solutions market are focusing on incorporating technological advancements such as isothermal nucleic acid amplification to enhance testing efficiency, portability, and diagnostic accuracy. Isothermal nucleic acid amplification is an advanced molecular diagnostic technology that amplifies target nucleic acid sequences at a constant temperature, eliminating the need for thermal cycling as in conventional polymerase chain reaction (PCR), thereby enabling rapid, sensitive, and compact molecular testing. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, received FDA marketing authorization for the Cue COVID-19 Molecular Test, an isothermal amplification-based diagnostic device designed for at-home and point-of-care detection of SARS-CoV-2 RNA. The system features a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that guides users through testing and delivers molecular results in about 20 minutes. The Cue COVID-19 molecular test improves access to accurate molecular-level diagnostics, reduces turnaround time, and supports real-time health decision-making outside traditional laboratory environments.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Near-Patient Molecular Solutions Market? Roche Acquires LumiraDx’s Point-Of-Care Technology Business To Strengthen Near-Patient Molecular And Decentralized Diagnostics Capabilities

In July 2024, Roche Holding AG, a Switzerland-based provider of in-vitro diagnostics and pharmaceutical solutions, acquired LumiraDx’s point-of-care (POC) technology business for $353.5 million. With this acquisition, Roche gains access to LumiraDx’s portable, multi-assay diagnostic platform, enhancing its decentralized and near-patient testing capabilities, broadening its presence in primary care and community-based settings, and improving delivery of rapid and reliable diagnostic results outside traditional laboratory environments. LumiraDx Group Limited is a UK-based provider of next-generation point-of-care diagnostics known for its compact instrument that integrates immunoassay, clinical chemistry, and emerging molecular testing capabilities in near-patient applications.

What Is The Regional Outlook For The Global Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market consists of sales of sample preparation devices, nucleic acid extraction kits, portable molecular analyzers, isothermal amplification kits, microfluidic cartridges, and multiplex detection panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Near-Patient Molecular Solutions Industry?

The near-patient molecular solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the near-patient molecular solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Near-Patient Molecular Solutions Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.54 billion
Revenue Forecast In 2034	$6.656 billion
Growth Rate	CAGR of 10.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Product Type, Technology, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Near-Patient Molecular Solutions Market Characteristics

3. Near-Patient Molecular Solutions Market Trends And Strategies

4. Near-Patient Molecular Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Near-Patient Molecular Solutions Growth Analysis And Strategic Analysis Framework

5.1. Global Near-Patient Molecular Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Near-Patient Molecular Solutions Market Growth Rate Analysis

5.4. Global Near-Patient Molecular Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Near-Patient Molecular Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Near-Patient Molecular Solutions Total Addressable Market (TAM)

6. Near-Patient Molecular Solutions Market Segmentation

6.1. Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infectious Diseases Testing Kits

Urinalysis Testing Kits

Tumor Or Cancer Markers

Pregnancy And Fertility

Hematology Testing Kits

Glucose Monitoring Kits

Drugs-Of-Abuse Testing Kits

Coagulation Monitoring Kits

Cardiometabolic Monitoring Kits

Other Product Types

6.2. Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR)-Based

Genetic Sequencing-Based

Hybridization-Based

Microarray-Based

6.3. Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Ambulatory Care Centres

Research Laboratories

Home Care Settings

Other End-Users

6.4. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hepatitis Testing Kits

Human Immunodeficiency Virus Testing Kits

Influenza Testing Kits

COVID-19 Testing Kits

6.5. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Testing Kits

Glucose Testing Kits

Ketone Testing Kits

Nitrite Testing Kits

6.6. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prostate-Specific Antigen Testing Kits

Carcinoembryonic Antigen Testing Kits

Cancer Antigen 125 Testing Kits

Alpha-Fetoprotein Testing Kits

6.7. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ovulation Testing Kits

Early Pregnancy Testing Kits

Digital Pregnancy Testing Kits

Home Fertility Monitoring Kits

6.8. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Complete Blood Count Testing Kits

Hemoglobin Testing Kits

White Blood Cell Count Testing Kits

Platelet Count Testing Kits

6.9. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Self-Monitoring Blood Glucose Kits

Continuous Glucose Monitoring Kits

Non-Invasive Glucose Testing Kits

Disposable Glucose Test Strips

6.10. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urine Drug Testing Kits

Saliva Drug Testing Kits

Hair Drug Testing Kits

Blood Drug Testing Kits

6.11. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prothrombin Time Testing Kits

International Normalized Ratio Testing Kits

Activated Partial Thromboplastin Time Testing Kits

D-Dimer Testing Kits

6.12. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cholesterol Testing Kits

Triglyceride Testing Kits

Low-Density Lipoprotein Testing Kits

High-Density Lipoprotein Testing Kits

6.13. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergy Testing Kits

Thyroid Function Testing Kits

Vitamin Deficiency Testing Kits

Liver Function Testing Kits

7. Near-Patient Molecular Solutions Market Regional And Country Analysis

7.1. Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Near-Patient Molecular Solutions Market

8.1. Asia-Pacific Near-Patient Molecular Solutions Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Near-Patient Molecular Solutions Market

9.1. China Near-Patient Molecular Solutions Market Overview

9.2. China Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Near-Patient Molecular Solutions Market

10.1. India Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Near-Patient Molecular Solutions Market

11.1. Japan Near-Patient Molecular Solutions Market Overview

11.2. Japan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Near-Patient Molecular Solutions Market

12.1. Australia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Near-Patient Molecular Solutions Market

13.1. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Near-Patient Molecular Solutions Market

14.1. South Korea Near-Patient Molecular Solutions Market Overview

14.2. South Korea Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Near-Patient Molecular Solutions Market

15.1. Western Europe Near-Patient Molecular Solutions Market Overview

15.2. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Near-Patient Molecular Solutions Market

16.1. UK Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Near-Patient Molecular Solutions Market

17.1. Germany Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Near-Patient Molecular Solutions Market

18.1. France Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Near-Patient Molecular Solutions Market

19.1. Italy Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Near-Patient Molecular Solutions Market

20.1. Spain Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Near-Patient Molecular Solutions Market

21.1. Eastern Europe Near-Patient Molecular Solutions Market Overview

21.2. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Near-Patient Molecular Solutions Market

22.1. Russia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Near-Patient Molecular Solutions Market

23.1. North America Near-Patient Molecular Solutions Market Overview

23.2. North America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Near-Patient Molecular Solutions Market

24.1. USA Near-Patient Molecular Solutions Market Overview

24.2. USA Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Near-Patient Molecular Solutions Market

25.1. Canada Near-Patient Molecular Solutions Market Overview

25.2. Canada Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Near-Patient Molecular Solutions Market

26.1. South America Near-Patient Molecular Solutions Market Overview

26.2. South America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Near-Patient Molecular Solutions Market

27.1. Brazil Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Near-Patient Molecular Solutions Market

28.1. Middle East Near-Patient Molecular Solutions Market Overview

28.2. Middle East Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Near-Patient Molecular Solutions Market

29.1. Africa Near-Patient Molecular Solutions Market Overview

29.2. Africa Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Near-Patient Molecular Solutions Market Competitive Landscape And Company Profiles

30.1. Near-Patient Molecular Solutions Market Competitive Landscape

30.2. Near-Patient Molecular Solutions Market Company Profiles

30.2.1. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Near-Patient Molecular Solutions Market Other Major And Innovative Companies

31.1. Siemens Healthineers AG

31.2. Hologic Inc.

31.3. bioMérieux SA

31.4. Sysmex Corporation

31.5. QuidelOrtho Corporation

31.6. QIAGEN NV

31.7. DiaSorin SpA

31.8. OraSure Technologies Inc.

31.9. Molbio Diagnostics Pvt Ltd

31.10. Cue Health Inc.

31.11. Biocartis Group NV

31.12. Vela Diagnostics Pte Ltd

31.13. Co-Diagnostics Inc.

31.14. Hyris Ltd

31.15. Genedrive plc

32. Global Near-Patient Molecular Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Near-Patient Molecular Solutions Market

34. Recent Developments In The Near-Patient Molecular Solutions Market

35. Near-Patient Molecular Solutions Market High Potential Countries, Segments and Strategies

35.1 Near-Patient Molecular Solutions Market In 2029 - Countries Offering Most New Opportunities

35.2 Near-Patient Molecular Solutions Market In 2029 - Segments Offering Most New Opportunities

35.3 Near-Patient Molecular Solutions Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: China, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: China, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: China, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: India, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: India, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: India, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Japan, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Japan, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Japan, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Australia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Australia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Australia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: South Korea, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: UK, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: UK, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: UK, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Germany, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Germany, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Germany, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: France, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: France, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: France, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Italy, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Italy, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Italy, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Spain, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Spain, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Spain, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Russia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Russia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Russia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: North America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: North America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: North America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: USA, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: USA, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: USA, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Canada, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Canada, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Canada, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: South America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: South America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: South America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Brazil, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Middle East, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Africa, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 82: Africa, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 83: Africa, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 84: Bosch Healthcare Solutions GmbH Financial Performance

Table 85: Roche Holding AG Financial Performance

Table 86: Thermo Fisher Scientific Inc. Financial Performance

Table 87: Abbott Laboratories Financial Performance

Table 88: Danaher Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: China, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: China, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: China, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: India, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: India, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: India, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Japan, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Japan, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Japan, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Australia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Australia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Australia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: South Korea, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: UK, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: UK, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: UK, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Germany, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Germany, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Germany, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: France, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: France, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: France, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Italy, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Italy, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Italy, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Spain, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Spain, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Spain, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Russia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Russia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Russia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: North America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: North America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: North America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: USA, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: USA, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: USA, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Canada, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Canada, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Canada, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: South America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: South America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: South America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Brazil, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Middle East, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Africa, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 82: Africa, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 83: Africa, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 84: Bosch Healthcare Solutions GmbH Financial Performance

Figure 85: Roche Holding AG Financial Performance

Figure 86: Thermo Fisher Scientific Inc. Financial Performance

Figure 87: Abbott Laboratories Financial Performance

Figure 88: Danaher Corporation Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Non-Therapeutic Biomolecules Global Market Report 2025 – By Trad Pharma( Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies), By End User( Research, Pharma, In vitro diagnostics(IV...

Clinical Chemistry Global Market Report 2025 – By Product (Analyzers, Reagents And Consumables ), By Application (General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel, Lipid Pr...

Small Molecule Drug Discovery Global Market Report 2025 – By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others),...

Small Molecule Injectable Drugs Global Market Report 2025 – By Drug Class (Small Molecule Antibiotics, Analgesics, Chemotherapy, Antivirals, Anticoagulant, Skeletal Muscle Relaxants, Anticonvulsants, Other Drug Class), B...

Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular...

Molecular Diagnostics Devices And Equipment Global Market Report 2025 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isot...

Drug Infusion Systems Global Market Report 2025 – By Product Type (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA...

Frequently Asked Questions

What is the definition of the Near-Patient Molecular Solutions market?

How will the Near-Patient Molecular Solutions market drivers and restraints affect the market dynamics? What forces will shape the Near-Patient Molecular Solutions industry going forward?

The market major growth driver - Surge In Demand For Home‑based Point‑Of‑Care Devices Fueling The Growth Of The Market Due To Increasing Consumer Autonomy And Convenience. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Near-Patient Molecular Solutions market?

The near-patient molecular solutions market size has grown rapidly in recent years. It will grow from $4.13 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing demand for rapid infectious disease diagnosis, rising prevalence of communicable diseases, growing focus on decentralized healthcare delivery, surge in point-of-care testing programs in public health systems, expansion of healthcare access in low- and middle-income countries, and rising awareness about early disease detection. The near-patient molecular solutions market size is expected to see strong growth in the next few years. It will grow to $6.656 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing burden of chronic and emerging infectious diseases, rising adoption of precision and personalized medicine approaches, growing integration of near-patient testing in primary care networks, surge in government initiatives to strengthen diagnostic infrastructure, expansion of community and home-based testing models, and rising healthcare expenditure supporting diagnostic accessibility. Major trends in the forecast period include technological advancements in microfluidic cartridge design, advancements in multiplex molecular assay platforms, innovations in sample-to-answer portable analyzers, developments in connectivity-enabled data reporting systems, research and development in reagent miniaturization for field applications, and innovations in fully automated near-patient molecular workflows. For further insights on this market, request a sample here

How is the Near-Patient Molecular Solutions market segmented?

The near-patient molecular solutions market covered in this report is segmented –
1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based
3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users Subsegments:
1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits
2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits
3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits
4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits
5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits
6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips
7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits
8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits
9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits
10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits For further insights on this market, request a sample here

Which region has the largest share of the Near-Patient Molecular Solutions market? What are the other regions covered in the report?

North America was the largest region in the near-patient molecular solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Near-Patient Molecular Solutions market?

What are the key trends in the Near-Patient Molecular Solutions market?

Major trends in this market include Integration Of Advanced Molecular Amplification Technologies To Enhance Near-Patient Diagnostic Performance. For further insights on this market, request a sample here.